NSC |
Compound |
Enrichment |
Correlation |
NSC 697912 |
5-Fluoro deoxy uridine 10mer |
0.0392716453377535 |
0.38790402 |
NSC 701023 |
Aceanthryleno[1,2-b]quinoxaline, 12-nitro- |
0.0392716453377535 |
0.14536252 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.0392716453377535 |
0.26880819 |
NSC 718630 |
Null |
0.0392716453377535 |
0.52223077 |
NSC 725098 |
Null |
0.0392716453377535 |
0.19086723 |
NSC 731701 |
1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate |
0.0392716453377535 |
-0.27662958 |
NSC 732936 |
5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.0392716453377535 |
0.23614563 |
NSC 734561 |
6-(3-chloropropyl)-6,11-dihydro-2,3-dimethoxy-5,11-dioxo-5H- indeno[1,2-c]isoquinoline-9-carbonitrile |
0.0392716453377535 |
0.3178919 |
NSC 735472 |
(2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol |
0.0392716453377535 |
0.10545646 |
NSC 741425 |
3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide |
0.0392716453377535 |
0.18498801 |